Gaetano Vitelli

888 total citations
28 papers, 673 citations indexed

About

Gaetano Vitelli is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Gaetano Vitelli has authored 28 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Gaetano Vitelli's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Multiple Myeloma Research and Treatments (4 papers). Gaetano Vitelli is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Multiple Myeloma Research and Treatments (4 papers). Gaetano Vitelli collaborates with scholars based in Italy, United States and Malaysia. Gaetano Vitelli's co-authors include Stefano Molica, Domenico Levato, G.M. Gandolfo, Vincenzo Liso, Angelo Vacca, Giovanna Digiesi, Antonio Cuneo, Diana Giannarelli, Doménico Ribatti and Marcella Mottolese and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gaetano Vitelli

27 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaetano Vitelli Italy 14 308 298 186 158 154 28 673
Radovan Vrḫovac Croatia 15 223 0.7× 330 1.1× 253 1.4× 227 1.4× 157 1.0× 65 810
Idanna Innocenti Italy 14 173 0.6× 336 1.1× 131 0.7× 227 1.4× 181 1.2× 75 638
J.J. Sotto France 11 179 0.6× 186 0.6× 178 1.0× 238 1.5× 125 0.8× 17 565
Eri Kawata Japan 14 279 0.9× 327 1.1× 188 1.0× 80 0.5× 134 0.9× 42 842
Łukasz Bołkuń Poland 14 187 0.6× 111 0.4× 160 0.9× 78 0.5× 158 1.0× 52 510
Amit Khot Australia 12 416 1.4× 253 0.8× 299 1.6× 340 2.2× 180 1.2× 53 971
Krzysztof Jamroziak Poland 20 357 1.2× 473 1.6× 493 2.7× 271 1.7× 204 1.3× 106 1.1k
Yuri Kamitsuji Japan 16 369 1.2× 294 1.0× 223 1.2× 108 0.7× 69 0.4× 32 929
Pearl Leavitt United States 10 268 0.9× 137 0.5× 255 1.4× 200 1.3× 104 0.7× 13 1.1k
Abelardo Bárez Spain 17 386 1.3× 309 1.0× 226 1.2× 175 1.1× 156 1.0× 42 918

Countries citing papers authored by Gaetano Vitelli

Since Specialization
Citations

This map shows the geographic impact of Gaetano Vitelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaetano Vitelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaetano Vitelli more than expected).

Fields of papers citing papers by Gaetano Vitelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaetano Vitelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaetano Vitelli. The network helps show where Gaetano Vitelli may publish in the future.

Co-authorship network of co-authors of Gaetano Vitelli

This figure shows the co-authorship network connecting the top 25 collaborators of Gaetano Vitelli. A scholar is included among the top collaborators of Gaetano Vitelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaetano Vitelli. Gaetano Vitelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitelli, Gaetano, Rosa Vona, Diana Giannarelli, et al.. (2009). Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation. Journal of Experimental & Clinical Cancer Research. 28(1). 35–35. 7 indexed citations
2.
Molica, Stefano, Giovanna Digiesi, Francesca Romana Mauro, et al.. (2008). Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. Leukemia Research. 33(1). 162–165. 12 indexed citations
3.
Molica, Stefano, Gaetano Vitelli, Giovanna Cutrona, et al.. (2008). Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia. Leukemia & lymphoma. 49(1). 62–67. 3 indexed citations
4.
Molica, Stefano, Gaetano Vitelli, Giovanna Cutrona, et al.. (2008). Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. International Journal of Hematology. 88(4). 374–380. 11 indexed citations
5.
Molica, Stefano, Giovanna Cutrona, Gaetano Vitelli, et al.. (2007). Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia. Leukemia Research. 31(11). 1575–1578. 24 indexed citations
6.
Merola, Roberta, Marcella Mottolese, F. Cognetti, et al.. (2006). Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis. European Journal of Cancer. 42(10). 1501–1506. 34 indexed citations
7.
Nisticò, Cecilia, Emilio Bria, Federica Cuppone, et al.. (2006). Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin–paclitaxel in metastatic breast cancer patients. Anti-Cancer Drugs. 18(2). 227–232. 15 indexed citations
8.
Greco, Carlo, Igea D’Agnano, Gaetano Vitelli, et al.. (2006). C-Myc Deregulation is Involved in Melphalan Resistance of Multiple Myeloma: Role of PDGF-BB. International Journal of Immunopathology and Pharmacology. 19(1). 67–71. 57 indexed citations
9.
Molica, Stefano, Gaetano Vitelli, Diana Giannarelli, et al.. (2006). Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease. Leukemia & lymphoma. 47(6). 1034–1040. 10 indexed citations
10.
Molica, Stefano, Gaetano Vitelli, Diana Giannarelli, et al.. (2005). Serum insulin‐like growth factor is not elevated in patients with early B‐cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. European Journal Of Haematology. 76(1). 51–57. 7 indexed citations
11.
Gandolfo, G.M., et al.. (2003). Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia. Medicina Clínica. 120(19). 725–727. 16 indexed citations
12.
13.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, et al.. (2003). Increased serum levels of matrix metalloproteinase‐9 predict clinical outcome of patients with early B‐cell chronic lymphocytic leukaemia. European Journal Of Haematology. 70(6). 373–378. 44 indexed citations
14.
15.
Molica, S., Gaetano Vitelli, Domenico Levato, Diana Giannarelli, & G.M. Gandolfo. (2001). Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Cancer. 92(4). 713–719. 30 indexed citations
16.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, G.M. Gandolfo, & Vincenzo Liso. (1999). Increased serum levels of vascular endothelial growth factor predict risk of progression in early B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 107(3). 605–610. 118 indexed citations
17.
López, M, Luigi Di Lauro, G Paoletti, et al.. (1995). Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects. Annals of Oncology. 6(10). 1011–1017. 13 indexed citations
18.
Ameglio, Franco, Anna Maria Cianciulli, Fabrizio Mattei, et al.. (1994). Selection of Patients with Monoclonal Grammopathy of Undetermined Significance is Mandatory for a Reliable Use of lnterleukin-6 and Other Nonspecific Multiple Myeloma Serum Markers. Acta Haematologica. 92(1). 1–7. 4 indexed citations
19.
López, M, F. Ameglio, Silvia Carpano, et al.. (1994). Biochemotherapy with thymosin α1, interleukin-2 and dacarbazine in patients with metastatic melanoma: Clinical and immunological effects. Annals of Oncology. 5(8). 741–746. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radovan Vrḫovac Breakdown of academic impact, for papers by Idanna Innocenti Breakdown of academic impact, for papers by J.J. Sotto Breakdown of academic impact, for papers by Eri Kawata Breakdown of academic impact, for papers by Łukasz Bołkuń Breakdown of academic impact, for papers by Amit Khot Breakdown of academic impact, for papers by Krzysztof Jamroziak Breakdown of academic impact, for papers by Yuri Kamitsuji Breakdown of academic impact, for papers by Pearl Leavitt Breakdown of academic impact, for papers by Abelardo Bárez
Rankless by CCL
2026